 brief-dur combin chemotherapi elderli patient poor-prognosi non-hodgkin lymphoma cur combin chemotherapi avail mani patient aggress non-hodgkin lymphoma nhl treatment elderli patient regimen difficult due excess toxic author patient year aggress nhl novel chemotherapi regimen bleomycin cyclophosphamid doxorubicin methotrex leucovorin prednison becalm dose intens toxic median age year histolog type follow intermedi grade larg cell larg cell intermedi grade unspecifi high grade small cell immunoblast sarcoma b-cell high grade unspecifi patient stage iii IV twenty-two patient follow tumor cm multipl extranod site dehydrogenas ldh iu/l small cell histolog type chemotherapi bleomycin IV week IV day day week IV week doxorubicin IV week IV week oral leucovorin rescu mg day week eighteen patient treatment cours complet respons CR patient continu CR median follow-up month relaps late relaps patient intercurr ill CR overal actual event-fre surviv major toxic neutropen fever mucos treatment-rel death author becalm chemotherapi elderli patient aggress nhl neurotox cumul toxic bleomycin anthracyclin regimen toxic respect myelosuppress treatment result regimen group patient multipl poor prognost featur